Molnupiravir drug helps reduce viral load in the early stages of Covid-19, reducing risks of severe symptoms and deaths.
Vietnam’s health ministry has just approved for the first time three Covid-19 treatment drugs containing Molnupiravir for emergency use.
The three drugs include Molravir 400 by Boston Pharma, Movinavir 200 mg by Mekophar Chemical Pharmaceutical, and Molnupiravir Stella 400 by Stellapharm, according to the Drug Administration of Vietnam under the Ministry of Health.
Packets of Molnupiravir for Covid-19 patients. Photo: Thai Son |
The administration said that when the drug was not yet approved and only the health ministry was allowed to distribute it to Covid-19 patients, it was sold illegally. Now that it is approved, the Molnupiravir market would be managed by the health ministry.
Molnupiravir drug helps reduce viral load in the early stages of Covid-19 and risks of severe symptoms and deaths, the administration added.
Molnupiravir has been used globally for mild and asymptomatic Covid-19 patients. The medication has proved to be safe and effective at reducing the risk of hospitalization and death in people with mild to moderate patients who are at increased risk of developing severe disease.
The use of the drug shows that Molnupiravir is safe and well-accepted, and has obvious effectiveness in reducing viral load, virus spread and the number of severe cases, and shortening treatment time, with no fatalities recorded.
Molnupiravir is developed by the US-based pharmaceutical companies Ridgeback Biotherapeutics and Merck & Co., Inc.
Earlier, in late November 2021, three Vietnamese pharmaceutical companies were planning to produce Molnupiravir pills to treat Covid-19 patients with mild or no symptoms.
Of the three, the drug manufactured by Stellapharm Vietnam has been approved for the clinical trial. At that time, because Molnupiravir had yet been granted a circulation registration number in Vietnam, the Ministry of Health is considering asking the Government for approval of using the drug in emergency cases.
Other News
- Hanoi launches pilot project to integrate electronic health records into VNeID app
- Modern pediatric hospital opens in Hanoi
- Hanoi to protect children against measles, rubella
- Hanoi works on cleanup, disease prevention after Typhoon Yagi
- Snoring and mouth opening/breathing during sleep can be signs of severe sleep apnea
- Hanoi, central provinces hold events to raise awareness of drowning prevention
- Australian vocational training delegation seeks Vietnam’s partners
- Inclusive data: Key to reaching those furthest behind
- Over 94% of Hanoi's population covered by medical insurance in H1
- Over 300,000 units of blood donated in Hanoi for five years
Trending
-
Vietnam's updated NAP: Progress in climate action
-
Vietnam news in brief - November 20
-
Prime Minister meets world leaders at G20
-
Hang Ma Street gears up for festive season
-
A Hanoi artisan turns straw into appealing tourism product
-
“Look! It’s Amadeus Vu Tan Dan” workshop - an artistic journey for kids
-
Vietnam news in brief - November 15
-
Experiencing ingenious spaces at the Hanoi Creative Design Festival 2024
-
Hanoi Festival of Creative Design 2024: celebrating the capital's cultural innovation